(Q36059702)

English

Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells (English)

1 reference

Europe PubMed Central

11 August 2017

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Marina Konopleva

7

object named as

Marina Konopleva

1 reference

Europe PubMed Central

11 August 2017

Michael Andreeff

8

object named as

Michael Andreeff

1 reference

Europe PubMed Central

11 August 2017

Juliana Maria Benito

6

object named as

Juliana Maria Benito

1 reference

Europe PubMed Central

11 August 2017

Sai-Ching Jim Yeung

10

object named as

Sai-Ching Jim Yeung

1 reference

Europe PubMed Central

11 August 2017

author name string

Jingxuan Pan

1

1 reference

Europe PubMed Central

11 August 2017

Chun Chen

2

1 reference

Europe PubMed Central

11 August 2017

Yanli Jin

3

1 reference

Europe PubMed Central

11 August 2017

Enrique Fuentes-Mattei

4

1 reference

Europe PubMed Central

11 August 2017

Guermarie Velazquez-Tores

5

1 reference

Europe PubMed Central

11 August 2017

Mong-Hong Lee

9

1 reference

Europe PubMed Central

11 August 2017

publication date

15 June 2012

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

11

1 reference

Europe PubMed Central

11 August 2017

12

1 reference

Europe PubMed Central

11 August 2017

2314-2326

1 reference

Europe PubMed Central

11 August 2017

A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Metformin use is associated with better survival of diabetic patients with pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Metformin: multi-faceted protection against cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Hallmarks of Cancer: The Next Generation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Metformin for aging and cancer prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Diabetes and cancer: a consensus report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Metronomic chemotherapy: new rationale for new directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Treatment with insulin glargine (Lantus) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

The AMPK-FoxO3A axis as a target for cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Metformin induces apoptosis of pancreatic cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Rosiglitazone inhibits adrenocortical cancer cell proliferation by interfering with the IGF-IR intracellular signaling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Proliferation of colo-357 pancreatic carcinoma cells and survival of patients with pancreatic carcinoma are not altered by insulin glargine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Peroxisome proliferator-activated receptor-gamma ligands for the treatment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

On the Origin of Cancer Cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

2 October 2017

Impaired leukocyte function in patients with poorly controlled diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

11 July 2018

Mortality from site-specific malignancies in type 2 diabetic patients from Verona

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Gemfibrozil considerably increases the plasma concentrations of rosiglitazone

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Activation of PPARgamma increases PTEN expression in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Postload plasma glucose concentration and 27-year prostate cancer mortality (United States).

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Insulin glargine and insulin have identical effects on proliferation and phosphatidylinositol 3-kinase/AKT signalling in rat thyrocytes and human follicular thyroid cancer cells.

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Insulin glargine and NPH insulin increase to a similar degree epithelial cell proliferation and aberrant crypt foci formation in colons of diabetic mice

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Activity of triptolide against human mast cells harboring the kinase domain mutant KIT.

1 reference

https://api.crossref.org/works/10.4161%2FCC.20770

21 January 2018

Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383592

23 September 2018

Proliferative effects of insulin analogues on mammary epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22659796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/22659796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22659796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements

1 reference

https://pubmed.ncbi.nlm.nih.gov/22659796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes: long-term use of insulin glargine might increase the risk of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22659796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of insulin levels after injection by jet stream and disposable insulin syringe

1 reference

https://pubmed.ncbi.nlm.nih.gov/22659796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/22659796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of diabetes mellitus on outcomes in patients with colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22659796

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4161/CC.20770

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36059702&oldid=2117033585"